Comparison of clinical pathways for hypoglossal nerve stimulation management: in-laboratory titration polysomnography vs home-based efficacy sleep testing

dc.contributor.authorKent, David
dc.contributor.authorHuyett, Phillip
dc.contributor.authorYu, Phoebe
dc.contributor.authorRo, Asim
dc.contributor.authorMehra, Reena
dc.contributor.authorVensel Rundo, Jessica
dc.contributor.authorStahl, Stephanie
dc.contributor.authorManchanda, Shalini
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-12-13T14:00:41Z
dc.date.available2024-12-13T14:00:41Z
dc.date.issued2023
dc.description.abstractStudy objectives: We conducted this study to evaluate whether laboratory or home-based hypoglossal nerve stimulation (HNS) management would have equivalent objective and subjective obstructive sleep apnea outcomes 6 months after activation. Methods: Patients undergoing standard-of-care HNS implantation were randomly assigned in a prospective, multicenter clinical trial to either a 3-month postactivation in-laboratory titration polysomnography (tPSG) or an efficacy home sleep study (eHST) with tPSG by exception for eHST nonresponders at 5 months. Both groups underwent an eHST 6 months postactivation. Results: Sixty patients were randomly assigned. Patients experienced equivalent decreases in the apnea-hypopnea index (mean difference: -0.01 events/h [-8.75, 8.74]) across both groups with HNS; the selection of tPSG or eHST did not associate with therapy response rates (tPSG vs eHST: 63.2% vs 59.1%). The Epworth Sleepiness Scale (median of differences: 1 [-1, 3]) and device usage (median of differences: 0.0 hours [-1.3, 1.3]) outcomes were similar but did not meet a priori statistical equivalence criteria. Conclusions: This prospective, multicenter, randomized clinical trial demonstrated that patients undergoing HNS implantation experienced statistically equivalent improvements in objective obstructive sleep apnea outcomes and similar improvements in daytime sleepiness regardless of whether they underwent tPSG. HNS titration with tPSG may not be required for all postoperative patients. Clinical trial registration: Registry: ClinicalTrials.gov; Name: Inspire Home Study: Utilization of Home Monitoring During Therapy Optimization in Patients With an Inspire Upper Airway Stimulation System (Comparison of Home Sleep Testing vs. In-lab Polysomnography Testing) (HOME); URL: https://clinicaltrials.gov/ct2/show/NCT04416542; Identifier: NCT04416542. Citation: Kent D, Huyett P, Yu P, et al. Comparison of clinical pathways for hypoglossal nerve stimulation management: in-laboratory titration polysomnography vs home-based efficacy sleep testing.
dc.eprint.versionFinal published version
dc.identifier.citationKent D, Huyett P, Yu P, et al. Comparison of clinical pathways for hypoglossal nerve stimulation management: in-laboratory titration polysomnography vs home-based efficacy sleep testing. J Clin Sleep Med. 2023;19(11):1905-1912. doi:10.5664/jcsm.10712
dc.identifier.urihttps://hdl.handle.net/1805/45024
dc.language.isoen_US
dc.publisherAmerican Academy of Sleep Medicine
dc.relation.isversionof10.5664/jcsm.10712
dc.relation.journalJournal of Clinical Sleep Medicine
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectHome sleep study
dc.subjectHypoglossal nerve stimulation
dc.subjectIn-laboratory polysomnography
dc.subjectObstructive sleep apnea
dc.subjectTitration
dc.titleComparison of clinical pathways for hypoglossal nerve stimulation management: in-laboratory titration polysomnography vs home-based efficacy sleep testing
dc.typeArticle
ul.alternative.fulltexthttps://pmc.ncbi.nlm.nih.gov/articles/PMC10620657/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Kent2023Comparison-PP.pdf
Size:
711.57 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: